Sun Pharmaceutical Industries dividend and valuation

SUNPHARMA · NSE · INR

Compare Sun Pharmaceutical Industries
₹1,880.00Change from previous close: −0.27%Absolute change: −₹5.00

Close · November 13, 2026

Valuation

Sun Pharmaceutical Industries paid ₹16.00 per share in dividends over the last 12 months (yield 0.9%). Last ex-dividend date: July 7, 2026. The P/E ratio is 40.9. The average price target of 33 analysts is ₹2,111.94.

Data as of November 17, 2026

Sun Pharmaceutical Industries compared with similar companies

Sun Pharmaceutical Industries's P/E (trailing 12 months): 40.9, in line with the median of a group of 11 similar companies (40.9).

Sun Pharmaceutical Industries's metrics compared with similar companies
MetricSun Pharmaceutical IndustriesMedian25th–75th percentileBand
P/E (trailing 12 months)40.940.928.2 – 83.4Middle
Forward P/E29.729.724.6 – 45.7Middle
EV/EBITDA24.426.917.8 – 43.4Middle
Price/book5.014.743.41 – 11.4Middle
Price/sales7.279.714.11 – 14.7Middle
Gross margin79.3%75.9%64.1% – 84.0%Middle
Operating margin23.3%24.1%19.7% – 32.8%Middle
Net margin17.8%17.8%13.0% – 32.2%Middle
ROE13.1%15.2%13.5% – 19.8%Low
Debt/equity0.040.110.02 – 0.44Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Sun Pharmaceutical Industries: valuation over time

On the latest fiscal year's earnings (2026), Sun Pharmaceutical Industries's P/E today is 39.3, in line with the median of its last 10 fiscal years (39.3; between 22.5 and 67.3 from 2017 to 2026). Relative to earnings, it costs about the same as in the past. The dividend yield (0.9%) is in line with the median of the last 10 fiscal years (0.9%).

Sun Pharmaceutical Industries P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
Mar 2026₹1,757.20₹47.8036.8₹16.000.9%
Mar 2025₹1,734.70₹45.5538.1₹16.000.9%
Mar 2024₹1,620.55₹39.9040.6₹13.500.8%
Mar 2023₹983.10₹35.3027.8₹11.501.2%
Mar 2022₹914.75₹13.6067.3₹10.001.1%
Mar 2021₹597.80₹12.1049.4₹7.501.3%
Mar 2020₹352.30₹15.6922.5₹4.001.1%
Mar 2019₹475.45₹11.1042.8₹2.750.6%
Mar 2018₹495.10₹8.7056.9₹2.000.4%
Mar 2017₹688.15₹28.9823.7₹3.500.5%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
₹4.48T
Enterprise value
₹4.17T
PEG
1.04
EV/revenue
6.77

Profitability and growth

ROA
8.2%
ROIC
18.4%
Revenue growth (year over year)
11.9%
Earnings growth (year over year)
-36.2%

Financial health

Total cash
₹335.7B
Total debt
₹32.41B
Current ratio
2.94
Quick ratio
2.18
Piotroski F-Score
5.00

Dividends

Annual dividend per share
₹16.00
Dividend yield
0.9%
Payout ratio
35.0%
Ex-dividend date
July 7, 2026

Analysts and estimates

Average price target
₹2,111.94
Median price target
₹2,140.00
High price target
₹2,320.00
Low price target
₹1,770.00
Analysts with a price target
33
Consensus
Buy
Forward EPS
₹62.79
EPS estimate, current year
₹53.50

Shares and trading

Beta
0.13
Average volume
1.8M
Shares outstanding
2.4B
Float
830.49M
Institutional ownership
29.5%
Insider ownership
55.6%